Archer

Ph.D Cand. Stock Filing reading enthusiast.

[Archer @ArcherKyun90]

@boogeymantradez Yes. $VYNE. These pre-funded warrants came with a provision for cashless exercise, I just re-checked the prospectus and confirmed again with the 10-Q CC.

[Archer @ArcherKyun90]

@TwoThreeXYZ @PPortfolioooo Still here sometimes! ha

[Archer @ArcherKyun90]

$RCAT 6 month check in, same price (ish). I think the macroenvironment has gotten better for them now though.

[Archer @ArcherKyun90]

$RCAT not the worst dilution ever, Lind may convert 1,650,000$ of shares per month with a floor price of .75 ~ at current prices ($9.30) thats only 175k shares. If share price drops lower then there are some dilutive problems but this is some fairly good financing.

[Archer @ArcherKyun90]

$RCAT not the worst dilution ever, Lind may convert 1,650,000$ of shares per month with a floor price of .75 ~ at current prices ($9.30) thats only 175k shares. If share price drops lower then there are some dilutive problems but this is some fairly good financing.

[unusualwhales.com Snorlax (๑❛ ڡ ❛๑) @snorlax_uw]

$FTAI short report

[Medexus Pharmaceuticals (TSX: MDP, OTCQX: MEDXF) @MedexusInc]

Health Canada Accepts for Review Medexus's New Drug Submission for Topical Terbinafine https://t.co/KdXg4LGSip

[Archer @ArcherKyun90]

@DakotasTwits Jjk enjoyer spotted 😂

[Archer @ArcherKyun90]

High hopes this year for @MedexusInc They've continued to execute their business plan and have been transparent with investors along the way. Unfortunate delay in Treo despite physician recommendations and data backing its greater effectiveness - still excited nonetheless!

[Archer @ArcherKyun90]

$MEDXF $MDP.TO Thread (3.5 year update). I originally discussed Medexus Pharmaceuticals back in November 2021 where they ran up to 7$ USD on Treosulfan approval hype. Currently they are trading around 2.15 USD in which Treosulfan is coming back around in hopes to be approved

[Archer @ArcherKyun90]

Recently https://t.co/jXHFvCpFZB did some estimates on Treo's capability I suggest taking a read through it. This with the possibility of Terbinafine being submitted/accepted puts the company in an excellent position for the future $ wise.

[Archer @ArcherKyun90]

$MEDXF $MDP.TO A good hold from 2020 till now. Lots to look forward to no matter what happens, company is in a pretty good position. 2024 looking great!

[Archer @ArcherKyun90]

@heydebigale Hey could you dm! I have a question

[Archer @ArcherKyun90]

$MEDXF $MDP Trading less than 1x EV/Revenue, no convertible debt, 40 million shareholder capital. Way undervalued here at 35 mil market cap..should be 3-4x this.

[No Exit @NExit007]

Low volume bleed under short control recently on $MEDXF $MDP. Meanwhile:
- Multiple analysts value it at $4-$5 Canadian while it sits at just over $2.
- Just paid off all their convertible debt in cash.
- Recent bought-deal offering fully sold out a full $1 above current price.

[Archer @ArcherKyun90]

@NExit007 Company is looking amazing, it will have its time